AJOONI BIOTECH LIMITED vs NESTLE INDIA LIMITED

A side-by-side comparison of AJOONI BIOTECH LIMITED (AJOONI) and NESTLE INDIA LIMITED (NESTLEIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, NESTLE INDIA LIMITED leads AJOONI vs NESTLEIND on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth20
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

15.04
P/E ratio
76.96
0.72
P/B ratio
52.54
0.00%
Dividend yield
0.97%
₹0.25
EPS
₹18.38

Profitability

NESTLEIND takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

3.83%
Return on equity
66.77%
3.72%
Return on capital
84.00%
3.43%
EBITDA margin
22.57%
2.37%
Net margin
15.11%

Growth

AJOONI takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

35.08%
Revenue CAGR (3Y)
6.58%
62.87%
Profit CAGR (3Y)
5.28%

Size & financial health

NESTLEIND takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹65 Cr
Market cap
₹2.77L Cr
₹182 Cr
Revenue
₹23,155 Cr
₹4 Cr
Net profit
₹3,499 Cr
0.19
Debt / equity
0.09
AJOONI BIOTECH LIMITED
  • + ["Stock is trading at 0.72 times its book value", "Company is expected to give good quarter", "Debtor days have improved from 48.8 to 35.7 days.", "Company's median sales growth is 35.1% of last 10 years", "Company's working capital requirements have reduced from 129 days to 93.5 days"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 30.5%", "Company has a low return on equity of 4.99% over last 3 years."]
NESTLE INDIA LIMITED
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 92.3%", "Company has been maintaining a healthy dividend payout of 74.3%"]
  • ["Stock is trading at 52.8 times its book value", "The company has delivered a poor sales growth of 11.6% over past five years."]
AJOONI BIOTECH LIMITED full analysis NESTLE INDIA LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.